Publications by authors named "Imogen J Swift"

Claim this Profile
P
Proteomic analysis reveals distinct cerebrospinal fluid signatures across genetic frontotemporal dementia subtypes.
Aitana Sogorb-Esteve, Sophia Weiner, Joel Simrén, Imogen J Swift, Martina Bocchetta

Sci Transl Med· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Differential patterns of lysosomal dysfunction are seen in the clinicopathological forms of primary progressive aphasia.
Imogen J Swift, Simon Sjödin, Johan Gobom, Ann Brinkmalm, Kaj Blennow

J Neurol· March 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A systematic review of progranulin concentrations in biofluids in over 7,000 people-assessing the pathogenicity of GRN mutations and other influencing factors.
Imogen J Swift, Rosa Rademakers, NiCole Finch, Matt Baker, Roberta Ghidoni

Alzheimers Res Ther· March 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Altered plasma protein profiles in genetic FTD - a GENFI study.
Abbe Ullgren, Linn Öijerstedt, Jennie Olofsson, Sofia Bergström, Julia Remnestål, Imogen J Swift

Mol Neurodegener· November 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Seed amplification and neurodegeneration marker trajectories in individuals at risk of prion disease.
Tze How Mok, Akin Nihat, Nour Majbour, Danielle Sequeira, Leah Holm-Mercer, Imogen J Swift

Brain· June 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Neurofilament light oligomers in neurodegenerative diseases: quantification by homogeneous immunoassay in cerebrospinal fluid.
Francisco J Meda, Kathryn Knowles, Imogen J Swift, Aitana Sogorb-Esteve, Jonathan D Rohrer

BMJ Neurol Open· February 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
CSF glial markers are elevated in a subset of patients with genetic frontotemporal dementia.
Ione O C Woollacott, Imogen J Swift, Aitana Sogorb-Esteve, Carolin Heller, Kathryn Knowles

Ann Clin Transl Neurol· November 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Temporal order of clinical and biomarker changes in familial frontotemporal dementia.
Adam M Staffaroni, Melanie Quintana, Barbara Wendelberger, Hilary W Heuer, Lucy L Russell, Imogen J Swift

Nat Med· October 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Elevated CSF and plasma complement proteins in genetic frontotemporal dementia: results from the GENFI study.
Emma L van der Ende, Carolin Heller, Aitana Sogorb-Esteve, Imogen J Swift, David McFall

J Neuroinflammation· September 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Differential impairment of cerebrospinal fluid synaptic biomarkers in the genetic forms of frontotemporal dementia.
Aitana Sogorb-Esteve, Johanna Nilsson, Imogen J Swift, Carolin Heller, Martina Bocchetta

Alzheimers Res Ther· August 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Development of a sensitive trial-ready poly(GP) CSF biomarker assay for -associated frontotemporal dementia and amyotrophic lateral sclerosis.
Katherine M Wilson, Eszter Katona, Idoia Glaria, Mireia Carcolé, Imogen J Swift

J Neurol Neurosurg Psychiatry· July 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A data-driven disease progression model of fluid biomarkers in genetic frontotemporal dementia.
Emma L van der Ende, Esther E Bron, Jackie M Poos, Lize C Jiskoot, Jessica L Panman, Imogen J Swift

Brain· June 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Plasma amyloid-β ratios in autosomal dominant Alzheimer's disease: the influence of genotype.
Antoinette O'Connor, Josef Pannee, Teresa Poole, Charles Arber, Erik Portelius, Imogen J Swift

Brain· November 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Differential chemokine alteration in the variants of primary progressive aphasia-a role for neuroinflammation.
Aitana Sogorb-Esteve, Imogen J Swift, Ione O C Woollacott, Jason D Warren, Henrik Zetterberg

J Neuroinflammation· October 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Variable clinical phenotype in TBK1 mutations: case report of a novel mutation causing primary progressive aphasia and review of the literature.
Imogen J Swift, Martina Bocchetta, Hanya Benotmane, Ione Oc Woollacott, Rachelle Shafei

Neurobiol Aging· March 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Fluid biomarkers in frontotemporal dementia: past, present and future.
Imogen Joanna Swift, Aitana Sogorb-Esteve, Carolin Heller, Matthis Synofzik, Markus Otto

J Neurol Neurosurg Psychiatry· February 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis